Amyloidosis is a group of clinical syndromes characterized by deposits of amyloid fibrils throughout the body. These fibrils are formed by aggregates of proteins that have not been properly folded. Deposits of amyloid fibrils ...
Oct 9, 2012
0
0
While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research published in the February ...
Feb 4, 2013
0
0
Depression in elderly people can include symptoms such as memory loss, making it hard to distinguish from the early stages of Alzheimer's disease and other types of dementia. A signature of Alzheimer's is accumulation of ...
Sep 23, 2020
0
4
Alzheimer's disease (AD) involves the deposition of a protein called amyloid β protein (Aβ) in the brain. This protein can build up in both the functional tissues, or "parenchyma", of the brain, and in the blood vessels. ...
Nov 30, 2021
0
1
From 'beer belly' to 'port wine stain', food imagery has a long history of being used in medicine to identify the diagnostic features of a wide range of conditions and ailments, says a pathologist in Medical Humanities.
Jul 9, 2014
0
0
The effort to find ways to detect and diagnose preclinical Alzheimer's disease (AD) has taken a big step forward with the use of positron emission tomography (PET), a "nuclear medicine" for imaging processes in the body, ...
May 24, 2016
0
4
(HealthDay)—As researchers hone in on ways to detect whether someone has a high risk of developing Alzheimer's disease before they have any symptoms, mental health professionals have worried what the psychological fallout ...
Aug 11, 2020
0
4
Amyloid beta pathology - protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.
Feb 15, 2018
0
5
Amyloid diseases, including Alzheimer's, Parkinson's, type-2 diabetes and other life-threatening diseases, involve pathologic deposits of normally soluble proteins or peptides as insoluble amyloid fibrils. When this happens ...
Jun 28, 2021
0
2
Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, shows a novel whole blood test developed by the company is able to quantify Alzheimer's disease biomarkers.
Oct 17, 2023
0
0
